Olatoyosi Odenike to Cross-Over Studies
This is a "connection" page, showing publications Olatoyosi Odenike has written about Cross-Over Studies.
Connection Strength
0.043
-
Oral cedazuridine/decitabine for MDS and CMML: a phase 2 pharmacokinetic/pharmacodynamic randomized crossover study. Blood. 2020 08 06; 136(6):674-683.
Score: 0.043
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.